Quick Answer: SCPN and CPNP are separate cosmetic notification systems. SCPN serves Great Britain, while CPNP is the European Commission’s portal under the EU Cosmetics Regulation and is relevant to the Northern Ireland route. A product intended for more than one market needs a market-specific compliance review. Neither notification replaces a safety assessment, product information file, compliant labeling or the appropriate responsible-person arrangement.
By mooyam_admin (MOOYAM editorial team). Last reviewed: 6 October 2026. Cover: AI-generated editorial illustration.
What is the core difference between SCPN and CPNP?
The distinction is jurisdiction, not which portal is more prestigious. The European Commission’s CPNP page describes a free notification system implementing Regulation (EC) No 1223/2009. It supplies information to competent authorities and poison centres. The Commission explains that a CPNP notification removes the need for further national cosmetic product notification within the EU; it does not remove other compliance obligations.
The UK OPSS notification guidance describes SCPN for Great Britain and identifies a separate Northern Ireland process. Do not choose a portal by the location of your factory, the language of your website or the currency of a sales invoice. Begin with where the product will be made available and the actual supply chain.
| Question | SCPN | CPNP |
|---|---|---|
| Which system? | UK Submit Cosmetic Product Notifications | European Commission Cosmetic Products Notification Portal |
| Primary planning context | Great Britain: England, Scotland and Wales | EU market; also relevant under the NI route |
| Who is central to compliance? | The responsible person under the applicable GB framework | The responsible person under the applicable EU framework; certain distributor duties also exist |
| Does notification prove safety? | No; supporting compliance work remains necessary | No; supporting compliance work remains necessary |
| Does one replace the other? | Do not assume substitution | Do not assume substitution |
Does a brand selling in both markets need two projects?
It needs a review of both sets of obligations, but that does not mean every technical task must be duplicated. A controlled formula specification, packaging information or a relevant laboratory report may be useful to more than one reviewer. The important question is whether that evidence is adequate for each market’s actual requirements, not whether the document has already been uploaded somewhere.
As a project-management recommendation, build one master product record with separate market-release sections. Keep common technical evidence together, then record the responsible person, approved artwork, applicable legal review and notification record for each destination. This reduces contradictory versions while preserving the decisions that must remain market specific.
For a broad launch sequence, compare our UK market-entry guide with the EU market-entry guide. This comparison focuses on coordination between notification routes rather than reproducing every launch requirement.
Where does Northern Ireland fit?
Northern Ireland must be considered explicitly. The official NI statutory guidance explains the EU cosmetics framework as it applies there, including notification and responsible-person arrangements. It also discusses movements of qualifying Northern Ireland goods to Great Britain.
A qualifying-goods provision is not a general instruction to route every overseas shipment through NI to avoid another requirement. Have a qualified professional review eligibility and any remaining GB duties. Record the facts used for that conclusion, including the economic operators and intended route, so a later logistics change triggers reassessment rather than silently invalidating the plan.
Are the responsible-person requirements interchangeable?
No. Confirm the legally appropriate establishment and appointment for each market. A service company may offer more than one market service, but the brand should still ask which legal entity holds each role and what documentation it can access. A name on an invoice does not establish the complete legal arrangement.
The current GB statutory guidance is the starting point for checking the GB framework and applicable transitions. Label-address transitions and the underlying responsible-person role are different questions. Do not copy an old deadline from an introductory portal guide into a new artwork instruction without checking the current provisions.
| Workstream | Manufacturer contribution | Brand and responsible-person coordination |
|---|---|---|
| Formula identity | Controlled composition and change information | Confirm each market review refers to the marketed version |
| Technical evidence | Available specifications and relevant test records | Identify gaps with qualified reviewers |
| Artwork | Packaging specifications and production feasibility | Approve market-specific information and claims |
| Notification | Supply agreed technical inputs | Confirm the responsible party, submission route and records |
| Changes | Notify agreed changes before implementation | Review affected dossiers, labels and portal records |
This is a recommended coordination matrix, not a transfer of statutory duties to the manufacturer. Agree the real scope of each party’s service in writing. Where proprietary formulation information is involved, arrange secure access for the qualified reviewer rather than relying on an incomplete marketing ingredient list.
Can the same safety report and product file be reused?
Do not assume automatic acceptance or automatic rejection. Ask the relevant assessor and responsible person to review the report against the product, intended use and applicable framework. A change to fragrance, packaging or intended users may matter even when the product name stays the same. A document’s title alone does not establish its suitability.
Use a gap assessment before ordering additional work. List what exists, what version it covers, who prepared it and what limitations it contains. Then request an explanation of what needs updating. This helps distinguish genuine evidence gaps from an administrative preference for a different file format.
What should a two-market launch checklist include?
- Write down every intended destination, including NI separately where relevant.
- Identify the responsible-person arrangement for each applicable framework.
- Freeze a traceable product version for technical review.
- Check ingredient, safety, labeling and claim requirements for each destination.
- Prepare the required notification inputs and real packaging material.
- Complete the applicable submissions and retain controlled records.
- Confirm the wider compliance work is complete before commercial release.
- Assign ownership of updates, complaints and regulatory enquiries.
Do not compress this into a claim that “two portal accounts equal two-market compliance.” Portal access is an administrative capability. Evidence review, appointment of the appropriate parties and compliant product presentation are substantive workstreams that need their own completion criteria.
How should brands compare service quotes?
Request itemized scope rather than a single unexplained “registration fee.” Distinguish administrative notification support from responsible-person services, safety assessment, testing, translation and artwork review. The Commission’s statement that CPNP is free concerns the portal; it does not mean a consultant’s wider professional work must be free.
A useful quotation states the product variants covered, excluded work, assumptions, renewal or ongoing services, and what happens if the formula changes. This is procurement advice, not a published regulatory price list. No universal cost or turnaround is claimed here.
Common comparison mistakes
- Describing SCPN as the UK name for the same CPNP database.
- Assuming a notification transfers all legal responsibilities to a factory.
- Treating a filing record as an endorsement of efficacy claims.
- Ignoring NI when a distributor says it serves “the UK.”
- Comparing prices without comparing the underlying service scope.
Frequently asked questions
Does CPNP alone cover Great Britain?
Do not assume it does. Assess GB notification requirements and any route-specific provisions separately.
Does SCPN cover an EU launch?
No. SCPN is not a substitute for the applicable EU notification and compliance requirements.
Is CPNP a paid government approval?
The Commission describes the portal as free. Notification is not a government safety approval; professional support can involve separate commercial fees.
Can one manufacturer support both projects?
A manufacturer can supply relevant information for both, subject to the agreed scope. Each responsible person and qualified reviewer must still determine what is needed.
Can I keep one master technical folder?
Yes as a document-control approach, provided market-specific decisions and required records remain clear, current and accessible to the appropriate parties.
Coordinate manufacturing evidence before launch
MOOYAM provides cosmetic OEM/ODM manufacturing and technical documentation support for international beauty brands. Review our OEM/ODM support and contact MOOYAM with your intended destinations and documentation requirements to clarify the manufacturing contribution.
Regulatory requirements may change. Brands should verify current requirements with the relevant regulatory authority or qualified compliance professional before placing cosmetic products on the market.